Structural Racism and HIV Pre-exposure Prophylaxis Use in the Nationwide US: A County-Level Analysis

被引:0
|
作者
Shi, Fanghui [1 ,2 ]
Mi, Tianyue [1 ,2 ]
Li, Xiaoming [1 ,2 ]
Ning, Huan [3 ]
Li, Zhenlong [3 ]
Yang, Xueying [1 ,2 ]
机构
[1] Univ South Carolina, South Carolina SmartState Ctr Healthcare Qual, Arnold Sch Publ Hlth, Columbia, SC 29208 USA
[2] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, 915 Greene St, Columbia, SC 29208 USA
[3] Penn State Univ, Dept Geog, Geoinformat & Big Data Res Lab, University Pk, PA 16802 USA
关键词
Structural racism; Pre-exposure prophylaxis; HIV; County level; UNITED-STATES; HEALTH; RISK; RACE;
D O I
10.1007/s40615-024-02127-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundStructural racism contributes to geographical inequalities in pre-exposure prophylaxis (PrEP) coverage in the United States (US). This study aims to investigate county-level variability in PrEP utilization across diverse dimensions of structural racism.MethodsThe 2013-2021 nationwide county-level PrEP rate and PrEP-to-need ratio (PNR) data were retrieved from AIDSVu. PrEP rate was defined as the number of PrEP users per 100,000 population, and PNR was defined as the ratio of PrEP users to new HIV diagnoses per calendar year. Linear mixed effect regression was employed to identify associations of county-level structural racism (e.g., structural racism in housing and socioeconomic status) with PrEP rate and PNR on a nationwide scale of the US.ResultsFrom 2013 to 2021, the mean PrEP rate and PNR increased from 3.62 to 71.10 and from 0.39 to 10.20, respectively. Counties with more structural racism in housing were more likely to have low PrEP rates (adjusted beta = - 5.80, 95% CI [- 8.84, - 2.75]). Higher PNR was found in counties with lower structural racism in socioeconomic status (adjusted beta = - 2.64, 95% CI [- 3.68, - 1.61]). Regionally, compared to the Midwest region, counties in the West region were more likely to have higher PrEP rate (adjusted beta = 30.99, 95% CI [22.19, 39.80]), and counties in the South had lower PNR (adjusted beta = - 1.87, 95% CI [- 2.57, - 1.17]).ConclusionsCounty-level structural racism plays a crucial role in understanding the challenges of scaling up PrEP coverage. The findings underscore the importance of tailored strategies across different regions and provide valuable insights for future interventions to optimize PrEP implementation.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Routine Data Analysis of HIV Pre-Exposure Prophylaxis Use and Rates of Sexually Transmitted Infections Since Coverage of HIV Pre-Exposure Prophylaxis by the Statutory Health Insurance in Germany
    Valbert, Frederik
    Schmidt, Daniel
    Kollan, Christian
    Droege, Patrik
    Klein, Melanie
    Schneider, Udo
    Friebe, Martin
    Wasem, Juergen
    Neumann, Anja
    ARCHIVES OF SEXUAL BEHAVIOR, 2024, 53 (09) : 3663 - 3672
  • [42] Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis
    Yoong, Deborah
    Naccarato, Mark
    Sharma, Malika
    Wilton, James
    Senn, Heather
    Tan, Darrell H. S.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (08) : 608 - 616
  • [43] TELEMEDICINE SOLUTIONS TO IMPROVE HIV PRE-EXPOSURE PROPHYLAXIS ACCESS IN FREMONT COUNTY, WY
    True, H. J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (01) : 151 - 152
  • [44] Pharmacists as providers of HIV pre-exposure prophylaxis
    Christine Bruno
    Parya Saberi
    International Journal of Clinical Pharmacy, 2012, 34 : 803 - 806
  • [45] Pre-exposure prophylaxis as HIV prevention in the UK
    Brady, Michael
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (03) : 150 - 152
  • [46] HIV moments and pre-exposure prophylaxis Reply
    Dunn, David T.
    Gafos, Mitzy
    White, Ellen
    McCormack, Sheena
    LANCET, 2016, 387 (10027): : 1508 - 1508
  • [47] Adherence and persistence of HIV pre-exposure prophylaxis use in the United States
    McCormick, Carter D.
    Sullivan, Patrick S.
    Qato, Dima M.
    Crawford, Stephanie Y.
    Schumock, Glen T.
    Lee, Todd A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [48] Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium
    Vanbaelen, Thibaut
    Rotsaert, Anke
    Jacobs, Bart K. M.
    Florence, Eric
    Kenyon, Chris
    Vuylsteke, Bea
    Laga, Marie
    Thijs, Reyniers
    AIDS PATIENT CARE AND STDS, 2022, 36 (04) : 159 - 167
  • [49] HIV pre-exposure prophylaxis: effective and underused
    Hempel, Amanda
    Biondi, Mia J.
    Baril, Jean-Guy
    Tan, Darrell H. S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (45) : E1544 - E1550
  • [50] Pharmacists as providers of HIV pre-exposure prophylaxis
    Bruno, Christine
    Saberi, Parya
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (06) : 803 - 806